Efficacy of Acupuncture in Refractory Irritable Bowel Syndrome
Condition:   Irritable Bowel Syndrome Intervention:   Other: Acupuncture Sponsors:   Chengdu University of Traditional Chinese Medicine;   Beijing University of Chinese Medicine Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 19, 2020 Category: Research Source Type: clinical trials

A randomized controlled trial investigating the effect of a diet low in fermentable oligosaccharides, disaccharides, monosaccharides, and polyols on the intestinal microbiome and inflammation in patients with ulcerative colitis: study protocol for a randomized controlled trial
This study is a randomized clinical trial. Thirty patients with mild to moderate ulcerative colitis will be randomly allocated to receive a low FODMAP diet (n = 15) or to continue their usual diet as control (n = 15), for 4 weeks. The quantity of intestinal microbiota including Clostridium cluster IV,Faecalibacterium prausnitzii, Rosburia spp., Lactobacillus spp., Bifidobacteria spp.,Akkermansia muciniphila,Bacteroides fragilis, and Ruminococcus spp., and theFirmicutes toBacteroidetes ratio and calprotectin and lactoferrin levels will be explored in fecal samples from patients. In additio...
Source: Trials - February 17, 2020 Category: Research Source Type: clinical trials

The DOMINO Trial: Diet Or Medication in Irritable Bowel syNdrOme
Condition:   Irritable Bowel Syndrome Interventions:   Other: IBS Diet;   Drug: Otilonium Bromide Sponsor:   Universitaire Ziekenhuizen Leuven Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 17, 2020 Category: Research Source Type: clinical trials

Randomised, double-blind, placebo controlled multi-centre study to assess the efficacy, tolerability and safety of Enterosgel ® in the treatment of irritable bowel syndrome with diarrhoea (IBS-D) in adults
DiscussionThis is the first large scale randomised controlled trial investigating Enterosgel ® in IBS-D. A study design with blinded phase followed by an open-label phase was chosen to encourage participation and study completion. Demonstrating that Enterosgel® is effective and safe in IBS-D could encourage adoption by patients and healthcare professionals and foster future clinical trial s assessing its use in related conditions.Trial registrationISRCTN17149988. Prospectively registered on 14 November 2017. (Source: Trials)
Source: Trials - January 29, 2020 Category: Research Source Type: clinical trials

Ethosuximide and Pentoxifylline in the Treatment of Abdominal Pain Related to Irritable Bowel Syndrome
Condition:   IBS - Irritable Bowel Syndrome Interventions:   Drug: pentoxyifylline;   Drug: Mebeverine;   Drug: ethosuximide Sponsor:   Tanta University Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - January 3, 2020 Category: Research Source Type: clinical trials

A Non-Interventional Pilot Study to Explore the Role of Gut Flora in IBS
Conditions:   Irritable Bowel;   Irritable Bowel Syndrome;   Irritable Bowel Syndrome With Diarrhea;   Irritable Bowel Syndrome Mixed;   Irritable Bowel Syndrome With Constipation;   Irritable Bowel Syndrome Without Diarrhea;   Irritable Bowel Syndrome Aggravated;   Irritable Bowel Syndrome Characterized by Constipation;   Irritable Bowel Syndrome Characterised by Alternating Bowel Habit Intervention:   Other: No intervention Sponsor:   ProgenaBiome Not ye...
Source: ClinicalTrials.gov - January 2, 2020 Category: Research Source Type: clinical trials

Effectiveness of Probiotics Stabilized With Cryoprotection Technology in Patients With Irritable Bowel Syndrome
Condition:   Irritable Bowel Syndrome Intervention:   Dietary Supplement: Probiotic Sponsors:   Children's Memorial Health Institute, Poland;   Medical University of Lublin Completed (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - December 20, 2019 Category: Research Source Type: clinical trials